Johnson Matthew W
Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, Maryland 21224, United States.
ACS Pharmacol Transl Sci. 2020 Dec 16;4(2):578-581. doi: 10.1021/acsptsci.0c00198. eCollection 2021 Apr 9.
This viewpoint identifies pitfalls in the study of psychedelic compounds, including those that pose challenges for the potential use of psychedelics as medicines. They are as follows: (1) Sloppiness regarding use of the term "consciousness". (2) Inappropriate introduction of religious/spiritual beliefs of investigators or clinicians. (3) Clinical boundaries and other ethical challenges associated with psychedelic treatments.
这一观点指出了迷幻化合物研究中的陷阱,包括那些对迷幻剂作为药物的潜在用途构成挑战的陷阱。具体如下:(1)在使用“意识”一词时不够严谨。(2)不恰当地引入研究者或临床医生的宗教/精神信仰。(3)与迷幻治疗相关的临床界限及其他伦理挑战。